Discussion
depression, Anxiety, heart disease, anxiety
AMI, HEART DISEASE
Anxiety and depression are prevalent in heart disease patients, which may lead to prolonged hospitalization and increased mortality in these patients [Apart from anxiety and depression, reduced quality of life is also a crucial problem in heart disease patients [Interestingly, the subgroup analysis found that patients with anxiety and depression at baseline might be benefited more from CBSM intervention in attenuating anxiety and depression, along with enhancing the quality of life at M6. The potential arguments might be that patients with anxiety and depression at baseline had severe psychological conditions; thus, the benefit of CBSM intervention might be stronger; in addition, patients could learn about this intervention after months; thus, they could conduct this intervention in their daily life, resulting in the reduction of anxiety and depression, and the enhancement of the quality of life at M6 [Although several interesting findings had been revealed, the limitations could not be omitted. Firstly, the long-term benefit of CBSM intervention in reducing anxiety and depression, along with ameliorating the quality of life in AMI patients who underwent PCI should be further explored. Secondly, the HADS score, EQ-5D score, and EQ-VAS score were self-assessed, which might lead to assessment bias. Thirdly, some individual-based psychotherapeutic interventions had been reported to improve mental health and quality of life [In conclusion, CBSM is a potential intervention in ameliorating anxiety, depression, and quality of life but does not affect MACE in AMI patients who undergo PCI. More shreds of evidence are required to validate the findings of this study.